[CLDX] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
29-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -53.97%
YoY- -109.63%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 153 3,480 685 3,786 668 236 2,728 -85.32%
PBT -20,679 -13,373 -16,538 -22,839 -14,224 -11,259 -12,625 38.91%
Tax -227 382 764 -939 1,088 -228 -16 485.10%
NP -20,452 -13,373 -16,538 -21,900 -14,224 -11,031 -12,625 37.89%
Tax Rate - - - - - - - -
Total Cost 20,605 16,853 17,223 25,686 14,892 11,267 15,353 21.64%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -13,367.32 -384.28 -2,414.31 -578.45 -2,129.34 -4,674.15 -462.79 839.47%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.45 -0.34 -0.42 -0.55 -0.36 -0.50 -0.73 -27.54%
EPS Diluted -0.45 -0.34 -0.42 -0.55 -0.36 -0.50 -0.73 -27.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.